Document Detail

Testican 3 expression in adult T-cell leukemia.
MedLine Citation:
PMID:  19144404     Owner:  NLM     Status:  MEDLINE    
Adult T-cell leukemia (ATL) is an aggressive disease characterized by visceral invasion, and ATL regulates matrix metalloproteinase (MMP) activities of the endothelial cells. The controlling system of MMP activities in ATL is regulated by various factors such as Emmprin and tissue inhibitor of MMP. In this study, we demonstrated that Testican 3 expression in ATL decreased the activity of MMP. Furthermore, we showed that the expression of Testican 3 was regulated by activating transcriptional factor 3 in human T-lymphotropic virus type I-related cell lines. Thus, Testican 3 is a novel regulator to reduce the activity of MMP in ATL.
Mikio Kamioka; Jun Imamura; Naoki Komatsu; Masanori Daibata; Tetsuro Sugiura
Related Documents :
10745274 - E1a stimulates fgf-2 release promoting differentiation of primary endothelial cells.
11242804 - Expression of tissue inhibitors of metalloproteinases (timps) in hepatocellular carcinoma.
20610254 - Distribution of inflammatory mediators in carotid and femoral plaques.
10797274 - Down-regulation of trypsinogen-2 expression by chemically modified tetracyclines: assoc...
10660064 - In vivo analysis of mutated initiation codons in the mitochondrial cox2 gene of sacchar...
9540834 - Contribution of proximal promoter elements to the regulation of basal and differential ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-01-13
Journal Detail:
Title:  Leukemia research     Volume:  33     ISSN:  1873-5835     ISO Abbreviation:  Leuk. Res.     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-05-05     Completed Date:  2009-05-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7706787     Medline TA:  Leuk Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  913-8     Citation Subset:  IM    
Department of Laboratory Medicine, Kochi University, Kochi 783-8505, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Activating Transcription Factor 3 / genetics,  metabolism*
Anisomycin / pharmacology
Blotting, Western
Cell Line, Transformed
Human T-lymphotropic virus 1 / genetics
Leukemia-Lymphoma, Adult T-Cell / genetics*,  metabolism,  pathology
Matrix Metalloproteinase 2 / antagonists & inhibitors*,  metabolism
Matrix Metalloproteinase 9 / antagonists & inhibitors*,  metabolism
Protein Synthesis Inhibitors / pharmacology
Proteoglycans / genetics*,  metabolism
RNA, Messenger / genetics,  metabolism
RNA, Small Interfering / pharmacology
Reverse Transcriptase Polymerase Chain Reaction
Tumor Cells, Cultured
Reg. No./Substance:
0/ATF3 protein, human; 0/Activating Transcription Factor 3; 0/Protein Synthesis Inhibitors; 0/Proteoglycans; 0/RNA, Messenger; 0/RNA, Small Interfering; 0/SPOCK3 protein, human; 22862-76-6/Anisomycin; EC Metalloproteinase 2; EC Metalloproteinase 9

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intrauterine growth restriction: implications for placental metabolism and transport. A review.
Next Document:  Success of short-term, higher-dose imatinib mesylate to induce clinical response in FIP1L1-PDGFRalph...